• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US STD Testing Devices Market

    ID: MRFR/HC/17986-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US STD Testing Devices Market Research Report By Type of Test (Serological Tests, Molecular Tests, Rapid Tests, Nucleic Acid Amplification Tests), By End User (Hospitals, Diagnostic Laboratories, Home Care Settings, Public Health Organizations), By Product Type (Test Kits, Equipment, Consumables) and By Application (Chlamydia Testing, Gonorrhea Testing, Syphilis Testing, HIV Testing, Hepatitis Testing) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US STD Testing Devices Market Infographic
    Purchase Options

    US STD Testing Devices Market Summary

    The US STD Testing Devices market is projected to grow from 1.75 billion USD in 2024 to 3 billion USD by 2035.

    Key Market Trends & Highlights

    US STD Testing Devices Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 5.02 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 3 billion USD, indicating robust growth potential.
    • In 2024, the market is valued at 1.75 billion USD, reflecting a strong demand for STD testing solutions.
    • Growing adoption of innovative testing technologies due to increasing awareness of sexually transmitted diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.75 (USD Billion)
    2035 Market Size 3 (USD Billion)
    CAGR (2025-2035) 5.02%

    Major Players

    Hologic, Laboratory Corporation of America, Roche Diagnostics, BioRad Laboratories, GenMark Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Alere, Cepheid, Siemens Healthineers, Quest Diagnostics, Syphilis Testing Services, ArcherDX, Becton Dickinson

    US STD Testing Devices Market Trends

    The US STD Testing Devices Market has been experiencing notable trends driven by increasing awareness around sexual health and the rise of preventive healthcare measures. A significant driver for this market is the growing prevalence of sexually transmitted diseases, prompting more individuals to seek timely testing and treatment. Public health initiatives, often supported by organizations such as the Centers for Disease Control and Prevention (CDC), emphasize the importance of regular testing, particularly among high-risk populations, which has contributed to spikes in demand for testing devices.

    Opportunities in the market are expanding, particularly with technological advancements in device development.The introduction of at-home testing kits that provide convenience and privacy can attract more users, especially among younger demographics who are inclined towards user-friendly solutions. Additionally, the integration of telehealth services with STD testing is a growing trend, offering patients the ability to consult healthcare professionals remotely and easily access testing options.

    In recent times, there has been a shift towards point-of-care testing devices which provide rapid results, enabling quicker diagnosis and treatment initiation. This trend aligns with the healthcare system's focus on improving patient outcomes and reducing the burden on clinics and hospitals.Furthermore, as public awareness campaigns evolve, they highlight the importance of regular screening, addressing stigma associated with STD testing, and encouraging higher testing rates across various demographic segments in the US. Overall, the landscape of the US STD Testing Devices Market is evolving, driven by awareness, technology, and public health initiatives, creating a proactive approach to managing sexual health.

    Market Segment Insights

    STD Testing Devices Market Type of Test Insights

    The US STD Testing Devices Market, classified by the Type of Test, presents a comprehensive landscape characterized by various testing methodologies, each catering to specific needs within the health sector. Serological Tests are widely recognized for their efficiency in detecting antibodies, thus playing a crucial role in the diagnosis of infections such as syphilis and HIV, significantly supporting public health strategies in the US. 

    Molecular Tests, known for their high sensitivity and specificity, have gained traction due to their capacity to detect the genetic material of pathogens, making them vital for early intervention in sexually transmitted infections.Rapid Tests contribute to the market by enabling quick results, essential for timely treatment and counseling, thus improving patient management and care. Nucleic Acid Amplification Tests (NAATs) stand out for their precision in identifying infections like chlamydia and gonorrhea, thus addressing the urgent need for accurate and prompt diagnostic tools.

    As awareness grows and healthcare systems evolve, the demand for these various testing types is expected to rise, aligning with national health objectives aimed at reducing STD rates and enhancing sexual health education among the population.

    Furthermore, the ongoing advancements in technology, alongside increasing funding for public health initiatives, create ample opportunities for growth in the US STD Testing Devices Market, making it a vital area for both healthcare providers and patients alike. The combination of innovative testing methods and an increased focus on preventive care ensures that the Type of Test segment remains a central component in the fight against STDs, emphasizing the importance of tailored testing solutions to improve overall public health outcomes.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    STD Testing Devices Market End User Insights

    The US STD Testing Devices Market has a diverse range of end users, each playing a crucial role in the overall landscape of sexual healthcare. Hospitals serve as primary facilities for patients seeking STD testing, offering comprehensive services that include counseling, testing, and treatment. Diagnostic laboratories are essential as they handle the processing and analysis of samples, often utilizing advanced technology for accurate results, which enhances both patient care and public health outcomes. 

    Home care settings have gained popularity due to the growing trend of at-home testing kits, providing individuals with convenience and privacy.Public health organizations are pivotal in promoting awareness and implementing screening programs, which significantly contribute to early detection and management of STDs, thus reducing transmission rates across communities. This varied segmentation allows for tailored approaches to testing and treatment, emphasizing the importance of accessibility and efficiency in the US STD Testing Devices Market. As awareness around sexual health continues to grow, the support from these end users will be vital for improving health outcomes and driving overall market growth.

    STD Testing Devices Market Product Type Insights

    The US STD Testing Devices Market exhibits a diverse Product Type segmentation, focusing primarily on Test Kits, Equipment, and Consumables. Test Kits play a crucial role in facilitating accessible and efficient STD screening for patients, effectively enhancing public health efforts across the country. They account for a significant portion of the market due to their ease of use and rapid results, which aligns with increasing demands for at-home and point-of-care testing solutions. 

    Equipment represents another vital category, typically consisting of laboratory analyzers and diagnostic instruments that support healthcare providers in accurate testing and timely diagnosis.This segment is essential for maintaining high testing standards and ensuring quality control in clinical settings. Meanwhile, Consumables, which include reagents and other disposable materials necessary for testing procedures, also dominate the market as they are vital for maintaining the operational readiness of testing facilities.

    The drive toward improved STD awareness and prevention, coupled with the growing utilization of advanced technologies in healthcare, continues to influence the US STD Testing Devices Market, enhancing growth opportunities for all Product Type segments.

    STD Testing Devices Market Application Insights

    The Application segment of the US STD Testing Devices Market focuses on various critical areas, including Chlamydia Testing, Gonorrhea Testing, Syphilis Testing, HIV Testing, and Hepatitis Testing. With the rising prevalence of sexually transmitted infections in the US, the importance of these testing applications cannot be overstated. Chlamydia and Gonorrhea Testing has gained significant attention due to their asymptomatic nature, leading to undiagnosed cases and potential complications, making routine screening vital for public health. 

    HIV Testing remains one of the most prominent applications as early detection is crucial for effective treatment and reducing transmission rates, supported by public health campaigns and increased awareness.Similarly, Hepatitis Testing serves a critical role in identifying infected individuals and facilitating timely intervention. Each of these applications contributes to the overall growth of the US STD Testing Devices Market, driven by increasing awareness, technological advancements in testing methods, and the growing need for effective disease management in the US healthcare system.

    As health organizations advocate for routine testing and screening, particularly among high-risk populations, these applications are expected to play a dominant role in shaping the future landscape of STD testing in the United States.

    Get more detailed insights about US STD Testing Devices Market

    Key Players and Competitive Insights

    The US STD Testing Devices Market is characterized by a rapidly evolving landscape driven by advancements in technology, increasing awareness regarding sexually transmitted infections, and a growing emphasis on preventive healthcare. With a broad array of testing devices available, including rapid tests, molecular diagnostics, and traditional laboratory tests, this market has become extremely competitive. Factors such as regulatory approvals, product innovation, strategic partnerships, and targeted marketing campaigns significantly influence the market dynamics. 

    Companies are vying for market share by enhancing their product offerings and expanding their distribution channels to meet the growing demand for reliable and efficient STD testing solutions across various demographics and healthcare settings. The competitive environment is additionally shaped by the increasing prevalence of sexually transmitted infections, pushing both established and emerging players to invest in research and development.

    Hologic has carved a significant niche in the US STD Testing Devices Market, known for its extensive portfolio of innovative diagnostic solutions. The company's strengths lie in its advanced molecular diagnostic technologies which provide rapid and accurate results, thereby improving patient outcomes. Hologic's commitment to quality, backed by a strong research and development framework, enables the company to launch cutting-edge products that cater to the specific needs of healthcare providers and patients. Moreover, the company's established relationships with healthcare facilities and its strategic marketing approaches have bolstered its market presence, ensuring that Hologic remains a competitive force in STD testing.

    The brand’s focus on women's health, particularly in STD diagnostics, has allowed it to build a strong reputation and foster significant trust within the healthcare community in the US.

    Laboratory Corporation of America stands as a prominent player in the US STD Testing Devices Market, offering a wide range of diagnostic services including testing for various sexually transmitted infections. The company is recognized for its high-quality laboratory services that blend advanced technology with an extensive testing catalog. Laboratory Corporation of America has built a formidable market presence through strategic mergers and acquisitions, which have expanded its service capabilities and geographic reach, thereby enhancing its competitive edge.

    Key products and services offered by the company in the STD testing space include innovative testing methodologies that provide faster results and improved accuracy. Its robust infrastructure and dedicated focus on customer service contribute to the company's strengths in maintaining a loyal client base. Furthermore, Laboratory Corporation of America’s commitment to research and continuous improvement in testing practices positions it well to adapt to the changing landscape of the STD testing market in the US.

    Key Companies in the US STD Testing Devices Market market include

    Industry Developments

    The US STD Testing Devices Market has seen significant developments recently, with Hologic and Abbott Laboratories continuing to innovate their product lines. In September 2023, Roche Diagnostics launched a new automated testing platform that aims to enhance the efficiency of STD testing in clinical laboratories across the US. Additionally, in October 2023, Quest Diagnostics announced a strategic partnership with GenMark Diagnostics to enhance rapid testing capabilities for multiple STDs. The market is also experiencing growth, as the rising incidence rates of STDs in the US, notably syphilis and chlamydia, are driving demand for advanced testing solutions.

    In terms of mergers and acquisitions, Thermo Fisher Scientific acquired a biotechnology firm in June 2023 to broaden its diagnostics offerings, while Siemens Healthineers completed an acquisition to strengthen its presence in molecular testing for STDs in August 2023. Over the past few years, regulatory bodies have been placing increased emphasis on STD prevention, which has propelled companies like Becton Dickinson and Alere to further invest in Research and Development initiatives tailored to expand testing availability. The ongoing innovations in the market reflect a strong commitment to enhancing public health outcomes in the United States.

    Market Segmentation

    STD Testing Devices Market End User Outlook

    • Hospitals
    • Diagnostic Laboratories
    • Home Care Settings
    • Public Health Organizations

    STD Testing Devices Market Application Outlook

    • Chlamydia Testing
    • Gonorrhea Testing
    • Syphilis Testing
    • HIV Testing
    • Hepatitis Testing

    STD Testing Devices Market Product Type Outlook

    • Test Kits
    • Equipment
    • Consumables

    STD Testing Devices Market Type of Test Outlook

    • Serological Tests
    • Molecular Tests
    • Rapid Tests
    • Nucleic Acid Amplification Tests

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 1.66(USD Billion)
    MARKET SIZE 2024 1.75(USD Billion)
    MARKET SIZE 2035 3.0(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.022% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Hologic, Laboratory Corporation of America, Roche Diagnostics, BioRad Laboratories, GenMark Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Alere, Cepheid, Siemens Healthineers, Quest Diagnostics, Syphilis Testing Services, ArcherDX, Becton Dickinson
    SEGMENTS COVERED Type of Test, End User, Product Type, Application
    KEY MARKET OPPORTUNITIES Telehealth integration for remote testing, Increased demand for at-home kits, Growing awareness and education initiatives, Advancements in rapid testing technology, Rising prevalence of STDs among youth
    KEY MARKET DYNAMICS Increasing sexually transmitted infections, Rising awareness and education, Growing demand for home testing, Technological advancements in devices, Expanding healthcare access and services
    COUNTRIES COVERED US

    FAQs

    What is the expected market size of the US STD Testing Devices Market in 2024?

    The US STD Testing Devices Market is expected to be valued at 1.75 billion USD in 2024.

    What is the projected market value for the US STD Testing Devices Market by 2035?

    By 2035, the US STD Testing Devices Market is projected to reach a value of 3.0 billion USD.

    What is the compound annual growth rate (CAGR) for the US STD Testing Devices Market from 2025 to 2035?

    The CAGR for the US STD Testing Devices Market is expected to be 5.022% from 2025 to 2035.

    Which type of test is anticipated to be the largest segment in the US STD Testing Devices Market in 2024?

    In 2024, Serological Tests are anticipated to be the largest segment with a value of 0.48 billion USD.

    What is the estimated market value for Molecular Tests in the US STD Testing Devices Market in 2035?

    The estimated market value for Molecular Tests by 2035 is expected to be 0.74 billion USD.

    Who are the key players in the US STD Testing Devices Market?

    Major players in the market include Hologic, Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers.

    What is the expected market size for Rapid Tests in 2024?

    The US STD Testing Devices Market for Rapid Tests is expected to be valued at 0.35 billion USD in 2024.

    How much is the market for Nucleic Acid Amplification Tests expected to grow by 2035?

    The market for Nucleic Acid Amplification Tests is expected to grow to 0.82 billion USD by 2035.

    What are the growth drivers for the US STD Testing Devices Market?

    Growth drivers include increasing awareness of sexually transmitted diseases and advancements in testing technologies.

    What challenges could impact the growth of the US STD Testing Devices Market?

    Challenges include regulatory hurdles and varying reimbursement policies impacting market accessibility.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials